Why did BOLT stock move up on 2026-10-23?
In plain English
The only news (“Bolt Biotherapeutics Presents Results from the Phase 1 Dos…”) is stale (546d old) — too old to explain today's move. Likely momentum, not news.
What it means for you
Spiked then faded — most of the early gain was given back by the close. Risk level: moderate.
Where this comes from
Observed market data. The price, percentage move, open, close and volume above are end-of-day figures for 2026-10-23 from XNAS, not estimates.
Sourced news. Articles published around 2026-10-23 that mention BOLT. We link them so you can read the original — we do not summarise them into a cause:
- Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025 — GlobeNewswire Inc. (2025-04-25)
- Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting — GlobeNewswire Inc. (2024-11-07)
- BOLT Investors Have the Opportunity to Lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm — GlobeNewswire Inc. (2024-09-02)
The most relevant article is stale (546d old), so it may not explain this particular session.
About Bolt Biotherapeutics, Inc. Common Stock
Bolt Biotherapeutics Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The company is focused on the clinical development of BDC-4182, its claudin 18.2 ISAC. Its other pipeline programs include CEA ISAC program a Boltbody ISAC targeting carcinoembryonic antigen cell adhesion molecule 5, or CEA; PD-L1 ISAC utilizes a novel human anti-PD-L1 antibody conjugat
BOLT — frequently asked
Why did BOLT stock move up on 2026-10-23?
The only news (“Bolt Biotherapeutics Presents Results from the Phase 1 Dos…”) is stale (546d old) — too old to explain today's move. Likely momentum, not news. Spiked then faded — most of the early gain was given back by the close.
See it in context
BOLT opened +66.6% versus the prior close, then finished -10.2% from its open, on 12.9M shares traded.
Against the whole market that day, 72.7% of US stocks closed higher (median move +1.0%) — so BOLT was moving with a broadly higher market. See the full market recap →
More movers: today's biggest gainers · today's biggest gap-ups · all screeners · why other stocks are moving
Learn the basics: how to read a chart · what volume means · grade BOLT’s chart with the AI reader →